Global CHA Network

CHA Medical Group

CHA Medical Group’s advanced stem cell technology

CHA Medical Group has filed the following patents related to stem cell and immunocyte research.

No	Patent Grants
71	[KR] Methods of producing human rpe cells and pharmaceutical preparations of human rpe cells (Registration number 10-2073730)
70	[JP] Enhanced umbilical cord adherent stem cells, method for producing and uses thereof (Registration number 06648259)
69	[KR] Pharmaceutical preparations of human RPE cells and uses thereof (Registration number 10-2054904)
68	[US] Postnatal adherent cells and preparation method therefor (Registration number 10479978)
67	[KR] Isolation of lung cancer cells and proliferation thereof using suspension culture method (Registration number 10-2043603)
66	[KR] A method for preserving of Nuclear Transfer Cells and banking system thereof (Registration number 10-2035075)
65	[KR] Enhanced postnatal adherent cells and use thereof (Registration number 10-2011634)
64	[KR] Method for subculture of human single pluripotent stem cell and method for preparing transformed human pluripotent stem cell using the same (Registration number 10-1972766)
63	[KR] Methods and systems for harvesting cells (Registration number 10-1910685)
62	[KR] Method and composition for proliferating of natural killer cell (Registration number 10-1909879)